(Q51370461)

English

Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy.

scientific article published on 22 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Weiqing Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Ruifang Bu

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Qing Su

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Jianying Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Guang Ning

5

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

language of work or name

0 references

publication date

22 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

12

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

18

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

2791-2799

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Prevalence of diabetes among men and women in China

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Diabetes in Asia: epidemiology, risk factors, and pathophysiology

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Standards of medical care in diabetes--2011.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Major causes of death among men and women in China

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Importance of postprandial glucose levels as a target for glycemic control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Earlier intervention in type 2 diabetes: the case for achieving early and sustained glycaemic control.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

The burden of treatment failure in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.602341

21 January 2018

Identifiers

10.1517/14656566.2011.602341

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21780853

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51370461&oldid=1242783549"